Litcius/Paper detail

Anti-granulocyte-macrophage colony-stimulating factor antibody otilimab in patients with hand osteoarthritis: a phase 2a randomised trial

Georg Schett, L.C. Bainbridge, Mario Berkowitz, Katherine Davy, Sofia Fernandes, Eduard N. Griep, Stephen Harrison, Anubha Gupta, James Lloyd‐Hughes, Alexandra H. Roberts, Mark Layton, Nonna Nowak, Jatin Patel, Jürgen Rech, Julia E. Smith, Sarah Watts, Paul P. Tak

2020The Lancet Rheumatology21 citationsDOI

Topics & Concepts

OsteoarthritisGranulocyte macrophage colony-stimulating factorMedicineAntibodyInternal medicineGranulocyteImmunologyPathologyCytokineAlternative medicineOsteoarthritis Treatment and MechanismsRheumatoid Arthritis Research and TherapiesPain Mechanisms and Treatments
Anti-granulocyte-macrophage colony-stimulating factor antibody otilimab in patients with hand osteoarthritis: a phase 2a randomised trial | Litcius